Filing Details
NUTRA PHARMA CORP (OTC:NPHC) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 19, 2026.
The Healthcare company reported Q0 revenue of .
10q filedOTC:NPHC
NUTRA PHARMA CORP (NPHC) Files Quarterly Report for Q0
NUTRA PHARMA CORP (OTC:NPHC) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 19, 2026.
At publication ·
What changed
NUTRA PHARMA CORP (OTC:NPHC) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- NUTRA PHARMA CORP (OTC:NPHC) filed its quarterly report (Form 10-Q) with the SEC on August 19, 2026, providing unaudited financial statements and management commentary on recent performance.
- The company's stock trades at $0.00 with a market capitalization of $7.1 million.
- The quarterly report includes updated risk factors and changes in business conditions, though specific revenue figures and financial metrics are not disclosed in this summary.
Market Context
NUTRA PHARMA CORP's stock currently trades at $0.00 with a market capitalization of $7.1M.
The 10-Q provides NUTRA PHARMA CORP's quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for NUTRA PHARMA CORP are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View NPHC Stock Page
Frequently Asked Questions
Where can I read NPHC's SEC filings?
Browse all filings on our NPHC SEC filings page.
What types of SEC filings does NUTRA PHARMA CORP file?
Public companies like NUTRA PHARMA CORP file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.